John N. Spencer's most recent trade in Geovax Labs Inc was a trade of 10,000 Common Stock done at an average price of $0.5 . Disclosure was reported to the exchange on Oct. 17, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Geovax Labs Inc | John N. Spencer | Director | Purchase of securities on an exchange or from another person at price $ 0.55 per share. | 17 Oct 2025 | 10,000 | 21,402 | - | 0.5 | 5,498 | Common Stock |
| Geovax Labs Inc | John N. Spencer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2025 | 10,000 | 10,000 | - | - | Stock Option | |
| Geovax Labs Inc | John N. Spencer | Director | Purchase of securities on an exchange or from another person at price $ 0.98 per share. | 10 Apr 2025 | 10,000 | 11,402 | - | 1.0 | 9,800 | Common Stock |
| Geovax Labs Inc | John N. Spencer, Jr. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2024 | 8,050 | 8,050 | - | - | Stock Option | |
| Geovax Labs Inc | John N. Spencer, Jr. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2023 | 50,000 | 50,000 | - | - | Stock Option | |
| Geovax Labs Inc | John N. Spencer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Dec 2021 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Geovax Labs Inc | John N. Spencer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Aug 2021 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| ClearPoint Neuro Inc | John N. Spencer | Director | Grant, award, or other acquisition of securities at price $ 19.57 per share. | 31 Mar 2021 | 319 | 24,361 (0%) | 0% | 19.6 | 6,243 | Common Stock |